• June 3-6, 2024
  • San Diego Convention Center, California

Sessions

Loading

Strategies for Antimicrobial Access in LMICs

Tuesday, June 04, 2024
Breakout Session
Infectious Disease and Vaccines
29C
Despite advances in disease treatment, much of the global population lacks access to these innovations. The pandemic highlighted many of the challenges in production and distribution of medicines to low- and middle-income countries (LMICs), and it demonstrated the importance of access to control infectious diseases. Antimicrobial resistance (AMR) also threatens global health, and resistance in LMICs contributes to what many call the ‘silent pandemic’. People in LMICs have limited antibiotic options, leading to patients being treated with suboptimal or ineffective antibiotics, which contributes to resistance. Recently, agreements were signed between pharmaceutical companies and non-profit organizations that promise to accelerate access to antimicrobial products in LMICs. This panel will cover the structure of these collaborations, describe key aspects for success, and advise on how these efforts can be expanded to bring greater access to more products in the future.
Speakers
Monika Schneider, PhD
Director, Global AMR Policy
Shionogi
Kevin Outterson
Executive Director
CARB-X
Yann Ferrisse
Business Development & Partner Engagement Director
GARDP Foundation
Back to Session List

BIO DOUBLE HELIX SPONSORS

Thanks to our sponsors for supporting our mission to drive a revolution to cure patients, protect our climate, and nourish humanity.

Loading

BIO HELIX SPONSORS